SR9009 improves heart function after pressure overload independent of cardiac REV-ERB

Hui Li1, Shiyang Song2, Chih-Liang Tien1

  • 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.

Insights

Genetic deletion of REV-ERB in heart cells worsens pressure overload damage. The drug SR9009 still protects the heart in these mice, indicating REV-ERB-independent mechanisms are involved in its cardioprotective effects.

Area of Science:

  • Cardiovascular Biology
  • Chronobiology
  • Molecular Cardiology

Background:

  • The core clock component REV-ERB plays a crucial role in maintaining heart function.
  • REV-ERB agonist SR9009 has shown promise in ameliorating cardiac remodeling following pressure overload.
  • The precise mechanism of SR9009's action, particularly its reliance on cardiac REV-ERB, remains unclear.

Purpose of the Study:

  • To investigate the role of cardiac REV-ERB in response to pressure overload.
  • To determine if the cardioprotective effects of SR9009 are mediated through cardiac REV-ERB.
  • To elucidate the mechanisms underlying SR9009's protective effects on the heart.

Main Methods:

  • Generation of REV-ERBα/β cardiac-specific double knockout (cDKO) mice.
  • Induction of pressure overload using the transverse aortic constriction (TAC) model.
  • Administration of SR9009 at different time points relative to REV-ERB expression cycles.

Main Results:

  • REV-ERB cardiac deficiency exacerbated cardiac myopathy and adverse remodeling after TAC in cDKO mice compared to wild-type controls.
  • SR9009 demonstrated significant cardioprotective effects against TAC-induced injury in cDKO mice, independent of cardiac REV-ERB.
  • The timing of SR9009 administration did not alter its cardioprotective efficacy, further supporting REV-ERB-independent pathways.

Conclusions:

  • Cardiac REV-ERB is critical for protecting the heart against pressure overload-induced damage.
  • SR9009 exerts cardioprotection through mechanisms independent of direct REV-ERB signaling in cardiomyocytes.
  • These findings reveal novel insights into the therapeutic potential of SR9009 for heart conditions.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
497
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
1.3K
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart...
1.2K